Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients

Overview of attention for article published in OncoTargets and therapy, April 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 2 X users

googleplus: 1 Google+ user

Citations

dimensions_citation: 50 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Google+ Dimensions citations

So far, Dimensions has found 50 publications that cite this research output.

50

The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.

The Crosstalk between Nerves and Cancer—A Poorly Understood Phenomenon and New Possibilities

Article in Cancers (May 2024)

Salbutamol, a short acting beta-2 agonist, reduces risk and improves prognosis of prostate cancer

Preprint in medRxiv (February 2024)

Concomitant antihypertensive medication and outcome of patients with metastatic castration‐resistant prostate cancer receiving enzalutamide or abiraterone acetate

Article in Cancer Medicine (January 2024)